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Azotemia-induced changes in serum protein binding may
affect kinetics, removal and toxicity of drugs [1] and of
azotemic retention products [2, 31, and may thus have impor-
tant implications on the course and treatment of the uremic
syndrome.
Although several compounds have been claimed to displace
protein bound solutes and drugs, the relative importance of
each of these displacers has not yet been evaluated and the
question as to whether there are still other potent but uniden-
tified inhibitors remains open [I].
One reason for this lack of information is that the complete-
ness of ligand extraction with most of the deproteinization
methods currently used [4—12] is uncertain. Comparative stud-
ies of different deproteinization methods are to our knowledge
non-existent, and this makes the choice of the most appropriate
method(s) virtually impossible.
The ability of 12 deproteinization methods to release bound
azotemic ligands has therefore been compared by simultaneous
measurement of several identified and unidentified compounds
by HPLC with UV detection. The results indicate that there are
substantial differences in the yield of ligand deproteinization,
depending on the methods used.
Methods
HPLC analyses
HPLC analyses on azotemic sera were performed with an
apparatus consisting of two LKB 2150 high pressure pumps and
an LKB 2152 gradient controller (LKB, Bromma, Sweden).
The autoinjector LKB 2153 was provided with a loop of 100 p1.
The analyses were performed on an UltrasphereTM-ODS re-
versed phase C18 column with a particle size of 5 t,a length of
25 cm and an inner diameter of 4.6 mm (Beckman Instruments
Inc., Galway, Ireland, UK). A guard column (5 cm x 4.6 cm)
was used to protect the main column from contaminants.
A linear solvent gradient from 100% buffer (formic acid 50
mmol/liter, and ammonia added to pH 4.0) to 60% eluent
(methanol) was used over 45 minutes, followed by a steeper
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gradient up to 80% eluent at 50 minutes. The flow rate was 0.90
mI/mm. The solvent was degassed by helium. The column was
kept at room temperature and solutes were measured by UV
detection at 254 nm (LKB 2238 Uvicord S II, Bromma, Swe-
den). A photodiode array detector (HP lO4OA, Hewlett-Pack-
ard, Waldbronn, Germany) was coupled in series with the
ultraviolet detector.
Peak heights were registered by an HP 3390 A integrator
(Hewlett-Packard, Avondale, Pennsylvania, USA), at attenua-
tion 3; a full scale deflection corresponded to 6.4 l0 equivalent
height counts, or 8 mY, or 0.016 absorption units.
Twelve deproteinization methods
In a preliminary study, 12 deproteinization methods were
compared for ligand extraction capacity on azotemic sera by an
evaluation of the number of individual UV-absorbing HPLC-
peaks, and the number of peaks which increased at least 25% in
height after deproteinization. The following methods were
submitted to this evaluation: heat denaturation [4], two meth-
ods of acetonitrile extraction [5, 61, two methods using tn-
chloroacetic acid [5, 7], bilirubin displacement [8], acid precip-
itation combined to ethylacetate or acetonitrile extraction [9,
101, the zinc hydroxide method [5], two methods using perchlo-
nc acid [5, 11], and the sodium tungstate method [12]. The five
methods with the highest yield in this first screening approach
(Table 1) were evaluated further:
(I) Heat denaturation. Serum (1 ml) was diluted with 2 ml of
highly purified water. Vortex mixing (10 seconds) was followed
by heating on a Bunsen burner (15 seconds) under continuous
and vigorous shaking to 90°C (measured by thermometer at the
end of the exposure), and ultrafiltration through a 30,000 D
anisotropic hydrophilic ultrafiltration membrane (CentrifreeTM,
Amicon, Danvers, Massachusetts, USA) at 1,800 x g for 60
minutes. This approach was a modification of previously de-
scribed methods [4]. Serum heated in a liquid water bath with
temperature control (90°C) yielded less supernatant material,
and was for this reason not used further. The HPLC-profile was
however the same as for the first method.
(II) Acetonitrile extraction. Serum and acetonitrile (0.3 and
1.5 mI—organic phase at 83%) were mixed, centrifuged, and 1.0
ml of the supernatant was evaporated under reduced pressure
and redissolved in 0.5 ml ammonium formate (50 mmol/l, pH
4.0) [6].
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Table 1. Effect of 12 deproteinization methods on azotemic serum
HPLC pattern
Number of
peaks after Peaks
deproteini- increasing
No. Method zation by >25%
I Heat denaturation 54 23
II Acetonitrile extraction A 46 19
III Trichioroacetic acid A 52 14
IV Bilirubin displacement 50 17
V Acid prec. & acetonitrile extr. 45 18
VI Zinc hydroxide 22 12
VII Perchioric acid A 19 7
VIII Sodium tungstate 18 15
IX Acetonitrile extraction B 18 10
X Acid prec. & ethylacetate extr. 17 11
XI Perchioric acid B 14 4
XII Trichioroacetic acid B 5 3
(III) Trichioroacetic acid (TCA). After the addition of 50 p1
TCA (612 mmol/liter) to 1 ml serum, and vortex mixing (10
seconds), the mixture was allowed to stand (20 mm), and
ultrafiltered; 0.4 ml was diluted with 0.8 ml water [71.
(IV)Bilirubin displacement. Serum (1 ml) and 100 p1 bilirubin
(2.5 mmol/liter), dissolved in 50 mmol/liter NaOH were mixed,
allowed to stand in the dark for 20 minutes, diluted I volume
with water (3 vol) and ultrafiltered with a CentrifreeTM filter [81.
(V) Acid precipitation/acetonitrile extraction. After vortex
mixing of 0.5 ml serum, 20 p1 hydrogen chloride 6 mol/liter, 20
p.1 glacial acetic acid, 150 mg sodium chloride and 2.5 ml
acetonitrile, and centrifugation, 1.0 ml of the mixture was
evaporated under reduced pressure. The dried substance was
redissolved in 0.5 ml ammonium formate (50 mmol/liter, pH 4.0)
[9].
Pre-diah'sis sera
A pool of pre-dialysis sera was prepared from five patients
and all experiments were performed in triplicate. Samples were
transported on crushed ice, centrifuged and stored at —70°C
until use. The basic characteristics of the sera used for the
composition of the pool were: Na 139.4 3.1 mEq/Iiter; K
5.1 0.6 mEq/liter; BUN 0.9 0.2 g/liter; creatinine 11.1 2.7
mg/dl; Ca 10.3 0.8 mg/dl; phosphorus 5.5 1.6 mg/dl; uric
acid 7.3 1.2 mg/dl.
The sera were submitted either to one of the deproteinization
methods, and were then considered to contain both free fraction
and ligands liberated from protein binding, or to ultrafiltration
(CentrifreeR), considered to correspond to the unbound fraction
in serum. The ultraffitrates were after ultrafiltration submitted
to a chemical and/or physical treatment identical to that for the
deproteinized sera, and compared to ultrafiltrates as such. This
was to exclude the generation of new compounds or the loss of
substances due to the experimental methodology. Similarly,
heat denaturated samples were thereafter submitted to each of
the five methods under study.
Ligand displacement studies
The ligand displacement studies in this evaluation were
limited to well differentiated peaks, which appeared in the
chromatograms of at least three deproteinization methods and
were characterized by a height > 1O equivalent height counts
(N 14). They received a rank number according to their
retention time and were tentatively identified from their UV
absorption spectra by intermutual comparison and comparison
with known azotemic solutes.
Protein binding (PB) was calculated as:
PB (1 — PHUF/PHdeprot) * 100
where PH is the peak height, respectively in the ultrafiltrates
and the deproteinized samples.
Protein elimination
The degree of protein elimination with these five methods
was evaluated by measurement of the protein concentration by
the Lowry method [13], before and after deproteinization. As a
blank run, highly purified HPLC water was submitted to the
same procedures as azotemic serum, to define the influence of
the reagents as such on the HPLC profile.
Recovery studies
Recovery studies (N = 7) were undertaken [14] by adding
four solutes to azotemic serum (increase in concentration:
hippuric acid 5.4 mgldl; indoxyl sulfate 3.6 mg/dl; tryptophan
0.73 mg/dl; indol-3-acetic acid 0.32 mg/dl). HPLC was per-
formed on the sera with and without the addition of the solutes,
after their submission to each of the deproteinization methods,
and the percentage of solute recovered was calculated.
Medications
Each of the medications taken by one or more patients who's
sera were used for the composition of the serum pool, were
diluted at concentrations 10 times higher than the effective
therapeutic concentration. The solutions were then submitted
to the same HPLC-procedure as the sera under study, to
disclose whether: (1) these drugs gave rise to an UV-absorbing
peak and (2) whether this peak coincided with any of the peaks
under study.
Statistics
Results are expressed as means standard deviation (means
SD) and were compared by paired analysis by ranks (Mann-
Whitney U), or for unequal groups, by unpaired Wilcoxon's
test.
Results
Blank runs of the five methods revealed no interference with
UV absorption on HPLC, except for the bilirubin displacement
method (no. IV), where two small peaks were observed after an
elution time of 44 and 47 minutes, respectively.
The protein content of the deproteinized substrates (Lowry
method), was reduced by more than 99.5%.
The effect of the five deproteinization methods on the extent
of protein binding is illustrated in Table 2. In Figure 1 the
elution time of the different peaks, and the effect of deprotein-
ization on peak height, are illustrated for the two methods with
the highest yields (methods I and II). All peaks were submitted
to UV spectral registration from 200 to 400 nm by photodiode
array detection (Fig. 2) and all peaks indicated by the same rank
number showed an identical spectrum, irrespective of the
deproteinization method used. Comparison with spectra of
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Table 2. Five deproteinization methods and their effect on protein binding for 14 selected peaks
Peak Method no.
no. I II III Iv V
1 49.6 3.4 46.6 3.7 45.1 7.2 45.1 0.2 NE
2 14.2 1.4k 5.8 4.6 NE 16.6 6.8a 6.3 4.2
3 74.1 0.9 80.0 0.3" 60.5 3.2 62.1 3.4 10.8 6.5"
4 33.8 47a 15.1 2.9 26.7 4.8 6.9 0.4" 11.4 2.6
5 42.8 1.9 30.6 1.9" 36.0 1.9 32.6 0.7 40.9 0.7
6 29.9 6.9 32.7 2.0 34.9 7.3 36.7 1.7 54.5 6.1"
7 84.4 0.7a 82.0 1.6 64.7 6.4 72.1 2.3 46.6 5.1"
8 50.8 2.1 44.1 1.1 37.7 2.0" 44.4 0.8 45.6 2.8
9 28.4 2.4 23.4 1.7 7.2 6.6 5.5 3.1" 37.3 5.2
10 70.7 0.7" 69.4 0.3 55.4 0.5" 64.4 0.8 66.0 1.8
11 48.6 1.2" 40.1 0.1 41.5 2.3 29.3 7.4 20.8 0.3"
12 100.0 100.0 100.0 100.0 NR
13 64.4 4.9 57.3 2.9 50.8 44 63.6 2.1 71.8 1.2"
14 34.4 0.6 43.0 32.7 1.7 NE 33.4 4.0
Percentage protein binding (means SD for triplicate estimations).
Abbreviations are: NE, not evaluated because of interference with other peaks; NR, not released after deproteinization (calculated protein
binding = 0).
Methods are: I, heat denaturation; II, acetonitrile extraction; III, trichioroacetic acid; IV, bilirubin displacement; V, acid precipitation!
acetonitrile extraction.
a p < 0.05, b P < 0.01 vs. the other methods
known azotemic solutes allowed us to tentatively identify the
following: indoxyl sulfate (no. 3), tryptophan (no. 4), hippuric
acid (no. 5) and indole-3-acetic acid (no. 11) (Fig. 3). Note that
not only the UV spectra, but also the retention times were the
same.
A substantial degree of protein binding was apparent for
several peaks. All these peaks eluted after the 14th minute,
once the methanol concentration in the eluate exceeded 19%.
Although this evaluation was limited to methods with a high
deproteinizing effect according to the first approach, the results
of the different methods were divergent. For most peaks,
calculated protein binding with at least one of the methods was
significantly different from the rest (Table 2). For peak 12,
protein binding was present according to most of the methods,
but ligand was not liberated from protein binding sites by one of
the methods. Interpretation of the results for peak 1 with
method V, for peak 2 with method III and for peak 14 with
method IV was difficult because of interference with other
peaks (for 14 with one of the bilirubin peaks).
The heat denaturation method (method no. I), in general gave
rise to the highest yield, confirming the results of the first part
of the study. By paired statistical analysis, this yield was
significantly higher than for the other deproteinization methods
(Table 3).
The left hand section of the chromatograms (up to an elution
time of 18 mm) for the acetonitrile extraction and the acid
precipitation/acetonitrile extraction methods (nos. II and V)
contained fewer substances both in the deproteinized samples
and the ultrafiltrates subsequently submitted to the experimen-
tal method than the chromatograms obtained with the other
deproteinization methods. This was attributed to the precipita-
tion and decreased solubility of solutes eluted in that zone in
relation to the reagents used.
The fact of submitting the ultrafiltrate to the deproteinization
methods after ultrafiltration gave rise to a similar yield as pure
ultrafiltrate, but two additional peaks (retention times 5 and 27
mm) were registered in the HPLC eluates of the samples
submitted to the acid precipitation/acetonitrile methods (no. V).
Submission of heat denaturated samples to each of the meth-
odological procedures, to submit a larger amount of solutes to
this test of generation of breakdown products, added no new
information.
The recovery studies yielded values in the range of 95 to
100%, excepted for tryptophan (44.3 2.2), indoxyl sulfate
(37.0 3.2) and indole-3-acetic acid (76.8 3.3) with method
IV, and for indole-3-acetic acid (84.2 7.6) with method V.
With method V, added indoxyl sulfate could insufficiently be
detected to allow calculation of recovery.
Seven of the drugs taken by the patients were visible on
HPLC as an UV absorbing peak: cefotaxime, ticlopidine,
furosemide, domperidone, dimethindene, sulfamethoxazole,
trimethoprim. None of these coincided however with one of the
peaks under study.
Discussion
Our comparison of deproteinization methods indicated that
the yield varied markedly (Table 1). These discrepancies can be
attributed to dilution, co-precipitation of ligands with proteins,
generation of insoluble compounds with reagents, differences in
solubility in organic solvents, interference in UV absorption
and incomplete release from binding sites.
Our approach allowed us to identify five methods with an
obviously higher yield than the others. Even among these five
methods, however, not all ligands were liberated to the same
extent (Table 2). Hence, we conclude that for protein binding
studies, several deproteinization methods used concomitantly
will offer more complete and reliable information, than single,
specific methods.
Among the five methods submitted to further evaluation, the
highest yield was obtained by heat denaturation (no. I), fol-
lowed closely by the acetonitrile extraction (no. II) and TCA
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methods (no. III) (Table 3). If a combination of methods is to be
considered, method number I, together with numbers II and/or
III should be proposed.
The question arises as to what extent do the deproteinization
methods, by reacting with ligands present, generate artefactual
new compounds. For that reason, ultrafiltrate and serum sub-
mitted to heat denaturation were given the same treatment as
azotemic serum. Apart from the acid precipitation/acetonitrile
method, which generated two unidentified new peaks, the
remaining methods did not cause the appearance of new major
peaks, Most peaks under study (apart from no. 12) were present
both in deproteinized samples and in ultrafiltrate and their
identity was confirmed by UV spectral array detection (Fig. 2).
It is thus unlikely that spurious compounds were evaluated.
Part of the deficient yield might be related to poor solubility
of some of the compounds rather than to poor displacement.
Fig. 1. Representative HPLC
chromatographs of ultrafiltrate (above), and
deproteinized sample (below) submitted to
50 heat denaturation (no. I) or acetonitrile
extraction (no. II). The 14 peaks that were
submitted to further evaluation of protein
binding are marked by a rank number.
This might especially be suspected for ionized solutes that are
poorly soluble at acid pH, as sometimes present during precip-
itation and/or subsequent solution. Such a bias was, however,
at least in part reduced by submitting both deproteinized
samples and ultrafiltrates to the same methodological treat-
ment.
All ligands with a substantial protein binding eluted after the
14th minute, that is, in the last two thirds of the elution time.
Among substances with similar general structure, elution time
on HPLC is directly correlated to protein binding and lipophil-
icity [15, 16].
The difficulties of achieving a quantitative extraction of
highly protein-bound, less hydrophilic solute remain, however,
and apply equally to endogenous and exogenous substrates.
Unfortunately, no proper "blanks" are available for endoge-
nous molecules, so as to assure that the deproteinization
I
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Fig. 2. Photodiode array spectra for UV
absorption from 200 to 400 nm for the 14
peaks under evaluation.
Fig. 3. Comparison of the photodiode array
spectra obtained for peaks 3, 4, 5, and 11,
and the corresponding spectra for indoxyl
sulfate, tryptophan, hippuric acid and indole-
3-acetic acid.
200 250 300 350 200 250 300 350
nm
lnodxyl sulfate Peak 3
200 250 300 350
nm
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Table 3. Average calculated protein binding for the 14 peaks submitted to the second step evaluation and statistical comparison by paired
analysis
II
Method no.
I
—
—--
Average prot binding 51.8 23.6 47.9 26.5 45.1 22.3 43.8 26.7 41.9 26.4
Statistical comparison (F)
I — <0.01 <0.001 <0.001 <0.05
II — <0.001 <0.01 NS
III — NS NS
IV — NS
V —
NS, statistically non-significant.
method indeed enabled the extraction of all ligand available on
the binding sites.
Reprint requests to R. Vanholder, M.D., Nephrology Department,
University Hospital, De Pintelaan, 185, B-9000 Ghent, Belgium.
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